Macdonald, D. A., Assouline, S. E., Brandwein, J., Kamel-Reid, S., Eisenhauer, E. A., Couban, S., Caplan, S., Foo, A., Walsh, W., & Leber, B. (2013). A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186. Leukemia and Lymphoma, 54(4), 760-766. https://doi.org/10.3109/10428194.2012.737917
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186. / Macdonald, David A.; Assouline, Sarit E.; Brandwein, Joseph et al.
In:
Leukemia and Lymphoma, Vol. 54, No. 4, 04.2013, p. 760-766.
Research output: Contribution to journal › Article › peer-review
Macdonald, DA, Assouline, SE, Brandwein, J, Kamel-Reid, S, Eisenhauer, EA, Couban, S, Caplan, S, Foo, A, Walsh, W & Leber, B 2013, 'A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186', Leukemia and Lymphoma, vol. 54, no. 4, pp. 760-766. https://doi.org/10.3109/10428194.2012.737917
Macdonald DA, Assouline SE, Brandwein J, Kamel-Reid S, Eisenhauer EA, Couban S et al. A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186. Leukemia and Lymphoma. 2013 Apr;54(4):760-766. doi: 10.3109/10428194.2012.737917
Macdonald, David A. ; Assouline, Sarit E. ; Brandwein, Joseph et al. / A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group : Trial IND.186. In: Leukemia and Lymphoma. 2013 ; Vol. 54, No. 4. pp. 760-766.
@article{8f1e670829774473b34fe7893ded7072,
title = "A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186",
author = "Macdonald, {David A.} and Assouline, {Sarit E.} and Joseph Brandwein and Suzanne Kamel-Reid and Eisenhauer, {Elizabeth A.} and Stephen Couban and Stephen Caplan and Alison Foo and Wendy Walsh and Brian Leber",
note = "Funding Information: This trial was supported in part by the Canadian Cancer Society Research Institute core grant to the NCIC Clinical Trials Group and by a research grant from Bayer Inc., Toronto, Canada.",
year = "2013",
month = apr,
doi = "10.3109/10428194.2012.737917",
language = "English",
volume = "54",
pages = "760--766",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",
}
TY - JOUR
T1 - A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group
T2 - Trial IND.186
AU - Macdonald, David A.
AU - Assouline, Sarit E.
AU - Brandwein, Joseph
AU - Kamel-Reid, Suzanne
AU - Eisenhauer, Elizabeth A.
AU - Couban, Stephen
AU - Caplan, Stephen
AU - Foo, Alison
AU - Walsh, Wendy
AU - Leber, Brian
N1 - Funding Information:
This trial was supported in part by the Canadian Cancer Society Research Institute core grant to the NCIC Clinical Trials Group and by a research grant from Bayer Inc., Toronto, Canada.
PY - 2013/4
Y1 - 2013/4
UR - http://www.scopus.com/inward/record.url?scp=84879150977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879150977&partnerID=8YFLogxK
U2 - 10.3109/10428194.2012.737917
DO - 10.3109/10428194.2012.737917
M3 - Article
C2 - 23061485
AN - SCOPUS:84879150977
SN - 1042-8194
VL - 54
SP - 760
EP - 766
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 4
ER -
